Study finds why some don't respond to rubella vaccine

May 1, 2013

Using advanced genetic sequencing technology and analysis, Mayo Clinic vaccine researchers have identified 27 genes that respond in very different ways to the standard rubella vaccine, making the vaccine less effective for a portion of the population. The findings appear today in the online journal PLOS ONE.

"This study highlighted the genes potentially responsible for poor response to the rubella vaccine," says Mayo Clinic vaccinologist Gregory Poland, M.D. "We found differences in genes responsible for antigen interactions, inflammation and differences in the gene pathways involved between low and high vaccine responders. It's another instance of using individualized medicine approaches to find potential solutions for patients not benefiting from standard treatments."

Researchers in the Mayo Clinic Group began with a random sample of 738 healthy children and young adults who had had two doses of the MMR (measles, mumps, and rubella) vaccine and then selected 25 individuals who represented either high or low responders. Samples from those participants were subject to sequencing of , resulting in transcriptional data that was analyzed for differences in gene expression.

This was the first Next Generation (high-speed, high-throughput) and analysis conducted after rubella vaccination that provided quantitative data. Researchers say the findings will help in efforts to better understand reactions to the existing rubella vaccine and be very useful in developing alternative vaccines so individuals in the low-response group can be adequately protected.

Explore further: Why does smallpox vaccine shield some, not others? It's in the genes, study finds

Related Stories

Why does smallpox vaccine shield some, not others? It's in the genes, study finds

April 18, 2013
How well people are protected by the smallpox vaccine depends on more than the quality of the vaccination: individual genes can alter their response, Mayo Clinic research shows. The findings, gathered using sophisticated ...

Third MMR vaccine dose can curtail mumps outbreak

November 5, 2012
(HealthDay)—Administering a third dose of the measles-mumps-rubella (MMR) vaccine reduced the village-wide attack rate by about 75 percent in a community experiencing a large mumps outbreak despite a high rate of previous ...

Mayo Clinic physician: Mistaken fear of measles shot has 'devastating' effect

August 30, 2011
More than 150 cases of measles have been reported in the United States already this year and there have been similar outbreaks in Europe, a sign the disease is making an alarming comeback. The reappearance of the potentially ...

Decoding vaccination: Researchers reveal genetic underpinnings of response to measles vaccine

September 22, 2011
Researchers at Mayo Clinic are hacking the genetic code that controls the human response to disease vaccination, and they are using this new cipher to answer many of the deep-seated questions that plague vaccinology, including ...

Man dies as UK measles epidemic spreads

April 19, 2013
U.K. authorities say a 25-year-old man is suspected to have died from measles as an epidemic continues to sweep across south Wales.

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.